Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

4.4K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast Myofibroblastoma: A Single Institutional Case Series.

European journal of breast health·2025
Same author

The utility and impact of digital endpoints for improving breast cancer outcomes.

Expert review of pharmacoeconomics & outcomes research·2024
Same author

Prioritizing Mammography Screening in Developing Countries: Are We Putting the Cart Before the Horse?

Annals of surgical oncology·2023
Same author

Breast cancer screening guidelines: discrepancies raise concerns about validity.

Breast cancer (Tokyo, Japan)·2023
Same author

Mitigating Cancer Overdiagnosis.

Indian journal of surgical oncology·2023
Same author

Tools for Contralateral Prophylactic Mastectomy Decision Making.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022
Same journal

Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Retraction: Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Optimizing the Uptake and Completion of the Cervical Cancer Screening Continuum: Opportunity Knocks, Including at Home.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Sex Differences in Cancer Stage at Diagnosis of Nonreproductive Solid Organ Tumors in the United States, 2015 to 2022.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Evaluation of the 4Kscore in EPIC: Reply.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same journal

Evaluation of the 4Kscore in EPIC: Letter.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.7K

Breast Cancer Screening: Can We Justify Deescalation?

Ismail Jatoi1

  • 1Division of Surgical Oncology and Endocrine Surgery, University of Texas Health Science Center, San Antonio, Texas.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
|May 1, 2024
PubMed
Summary
This summary is machine-generated.

New breast cancer screening methods detect more occult tumors, but this doesn't guarantee reduced mortality. Advances in therapy may allow for deescalating screening to reduce overdiagnosis risks.

More Related Videos

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.6K
X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
12:57

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

2.3K

Related Experiment Videos

Last Updated: Jun 27, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.7K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.6K
X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
12:57

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

2.3K

Area of Science:

  • Oncology
  • Radiology
  • Public Health

Background:

  • Novel breast cancer screening methods are widely adopted to decrease mortality.
  • Tumor detection rates have increased, but this has not been validated as a surrogate for mortality reduction.
  • Increased detection of occult cancers raises concerns about overdiagnosis.

Purpose of the Study:

  • To evaluate the necessity of current breast cancer screening practices in light of therapeutic advancements.
  • To propose a randomized trial comparing mammography and clinical breast examination (CBE) for breast cancer mortality.
  • To explore the potential role of ultrasound in enhancing CBE during screening.

Main Methods:

  • A randomized trial is proposed to compare screening mammography versus screening clinical breast examination (CBE).
  • The primary endpoint for this trial would be breast cancer mortality.
  • Hand-held ultrasound may be utilized to assist in interpreting CBE findings.

Main Results:

  • Increased detection of occult tumors does not equate to validated reduction in breast cancer mortality.
  • Advances in breast cancer therapy may allow for the cure of cancers detected later, challenging the necessity of early occult tumor detection.
  • Overdiagnosis, the detection of non-life-threatening tumors, is a significant risk associated with current screening practices.

Conclusions:

  • Recent improvements in breast cancer treatment justify reassessing and potentially deescalating screening protocols.
  • A randomized trial comparing mammography and CBE with mortality as the endpoint is warranted.
  • Deescalating breast cancer screening may mitigate the risks of overdiagnosis while maintaining or improving patient outcomes.